I purchased Nova Chemicals at an average per share cost of $6.12. I viewed it as being undervalued getting to this price. At it's current price, I think Nova is now a deep value play, and a perfect candidate for the sort of equity injection Fairfax Financial might give.
Any comments from the board?
Jonz